Search company, investor...
iSTAR Medical company logo

iSTAR Medical

istarmed.com

Stage

Project Finance | Alive

Total Raised

$120.6M

Last Raised

$60M | 6 mos ago

About iSTAR Medical

iSTAR Medical is a private, clinical-stage, medical technology company focused on the development of ophthalmic implants for glaucoma. iSTAR Medical's MIGS device, MINIjectTM, provides a safe, effective and sustainable solution to significantly reduce IOP by enhancing aqueous humor outflow from the anterior chamber to the supraciliary space.

Headquarters Location

Avenue Sabin, 6

Wavre, 1300,

Belgium

+32 (0)1077 16 54

iSTAR Medical's Product Videos

Compete with iSTAR Medical?

Ensure that your company and products are accurately represented on our platform.

iSTAR Medical's Products & Differentiators

    MINIject

    A minimally invasive glaucoma surgery device

Expert Collections containing iSTAR Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

iSTAR Medical is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,592 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

iSTAR Medical Patents

iSTAR Medical has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/27/2012

1/6/2015

Diseases of the eye and adnexa, Ophthalmology, Glaucoma, Eye surgery, Sensors

Grant

Application Date

4/27/2012

Grant Date

1/6/2015

Title

Related Topics

Diseases of the eye and adnexa, Ophthalmology, Glaucoma, Eye surgery, Sensors

Status

Grant

iSTAR Medical Frequently Asked Questions (FAQ)

  • Where is iSTAR Medical's headquarters?

    iSTAR Medical's headquarters is located at Avenue Sabin, 6, Wavre.

  • What is iSTAR Medical's latest funding round?

    iSTAR Medical's latest funding round is Project Finance.

  • How much did iSTAR Medical raise?

    iSTAR Medical raised a total of $120.6M.

  • Who are the investors of iSTAR Medical?

    Investors of iSTAR Medical include AbbVie, European Investment Bank, Capricorn Partners, Societe Regionale d'Investissement de Wallonie, La Societe Federale de Participations et d'Investissement and 11 more.

  • Who are iSTAR Medical's competitors?

    Competitors of iSTAR Medical include Ivantis and 1 more.

  • What products does iSTAR Medical offer?

    iSTAR Medical's products include MINIject.

Compare iSTAR Medical to Competitors

Implandata Ophthalmic Products Logo
Implandata Ophthalmic Products

Implandata Ophthalmic Products offers the EYEMATE system to empower people to take control of glaucoma – anytime and anywhere. EYEMATE is an AI-powered, cloud-based, data-centric platform for 24/7/365 monitoring and predictive modeling of disease progression. EYEMATE's data analytics combine IOP with other vital parameters to enable personalized therapies. For people with glaucoma, this means improved quality of life and peace of mind. For eye doctors, this means improved patient care at a significantly lower cost.

C
CytImmune Sciences

CytImmune Sciences is a clinical stage nanomedicine company with a core focus on the discovery, development and commercialization of multifunctional, tumor-targeted therapies.

C
Chakshu Research

Led by a team with vast experience in pharmaceuticals, ophthalmology and start-ups, Chakshu Research is committed to develop pharmaceutical treatments for degenerative ocular diseases. The company are developing a self-administered eyedrop to reduce and repair oxidative damage which has been implicated in blinding degenerative diseases. While the company's drug platform is being tested on the company's lead indication, cataract; the company are also in clinical trials for glaucoma and asteroid hyalosis.

E
ENTRA Pharmaceuticals

ENTRA Pharmaceuticals is a specialty pharmaceutical company developing therapies and improving existing treatments in areas with high unmet medical needs. In addition to the company's technology platform, ENTRA possesses strong expertise in preclinical and clinical drug development and commercialization.

C
CNSBio

Relevare Pharmaceuticals, formerly CNSBio, is a specialty pharmaceutical company focused on the development of novel therapies to treat chronic and acute pain. Relevare Pharmaceuticals exciting clinical-stage pipeline is comprised of programs that combine or reposition drugs known to be active at CNS targets that modulate pain perception and transmission, and for which there is strong safety evidence in humans. In April 2010, CNSBio rebranded to Relevare Pharmaceuticals.

K
KeyNeurotek Pharmaceuticals

KeyNeurotek Pharmaceuticals is a clinical stage small molecule company focused on autoimmune and CNS diseases.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.